ImmunoForge

Website

Operator of a drug development and pharmaceutical company intended to develop drugs for treating sarcopenia and cancer. The company's drugs specialize in targeting Duchenne muscular dystrophy, ALS, se...

Healthcare
Seoul, South Korea
Founded 2017
17 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$27.8M
Last Round
N/A
Investors
+14 other investors
View all 14 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock ImmunoForge's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required